Temazep-CT 20 mg is a European brand name (manufactured by AbZ-Pharma in Germany) for temazepam, a potent, intermediate-acting medication belonging to the benzodiazepine class. The 20 mg soft gel capsule (Weichkapsel) is specifically formulated as a sedative-hypnotic used for the short-term treatment of severe, clinically significant insomnia in adults Critical Risks and Adverse Interactions
• The "Black Box" Warning: Never combine Temazep-CT with alcohol, opioids, or other central nervous system depressants. Mixing these substances forces a dangerous synergy that can cause severe respiratory depression (slowed or stopped breathing), profound coma, and fatal overdose.
• Complex Sleep Behaviors: Users have reported performing tasks while completely asleep without any memory of the event, including sleep-driving, preparing food, walking, or making phone calls.
• Abrupt Cessation Hazards: Suddenly stopping a 20 mg dose after regular use can precipitate dangerous withdrawal symptoms. These include severe rebound insomnia, intense anxiety, tremors, sweating, hallucinations, and life-threatening seizures. Dose adjustments or stopping must always be tapered down under medical guidance.
• Contraindications: It is strictly forbidden for individuals with myasthenia gravis (severe muscle weakness), severe sleep apnea, severe respiratory depression, or advanced liver damage